INSIGHTS ON CLINICAL TRIAL PARTNERING

• Maximizing Site Performance: The Hidden Benefits Of Unified eConsent And EDC

  Disconnected systems for eConsent and EDC create inefficiencies that burden clinical trial teams, but modern integrated platform solutions are streamlining operations.

• Research Study Rockstar: Full -Service Trial Advertising Support

  Learn how clinical research organizations are combining digital marketing, community engagement, analytics, and technology integrations to improve patient recruitment

• Continuity And Risk Mitigation Following Unexpected QPPV Resignation

  Rapid escalation and clear interim governance ensured compliance and operational continuity following an unexpected QPPV resignation, reducing inspection risk during a critical pharmacovigilance transition.

• Use Case: A Patient-Centric Approach To Site Selection

  Discover how Citeline’s robust datasets, combined with real-world data, inform intelligent site and investigator selection for a rare, autoimmune disease. 

• Turning Innovation Into Execution In CNS Trials

  2/24/2026

  SCOPE 2026 experts called for practical planning, iterative testing, and real‑world workflows in mental health research, highlighting mock visits, expanded roles, engagement, and psychedelic safety.

   

   

   

   

   

• Building A Gold Standard Trial Experience In Japan

  4/4/2025

  Hear how Medable worked with a Japanese sponsor to elevate their trial experience, achieve >90% patient and site adherence, and beat their forecasted FPI date, creating new eCOA standards adopted across all the customer’s vendors.

• Accelerating A Global, FIH ADC Therapy Trial For Lung Cancer

  11/17/2025

  Choose a development partner who can navigate global execution, ADC-specific challenges, and Project Optimus requirements so your first-in-human study is designed and positioned for success.

• Urgent Compliance Recovery Following Vendor Transition

  5/26/2026

  Strong local leadership, clear ownership, and governed oversight drove rapid remediation of legacy safety gaps, restoring regulatory confidence and safeguarding market continuity.

• ASGCT Symposium: Community-Based Cell & Gene Therapy Delivery

  6/10/2026

  This symposium from ASGCT 2026 explores community-based delivery of cell & gene therapies as a means to improve access, equity, enrollment speed, data quality, and regulatory evidence.